Filing Details
- Accession Number:
- 0001415889-22-007625
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-11 16:30:20
- Reporting Period:
- 2022-07-07
- Accepted Time:
- 2022-07-11 16:30:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1231617 | Raymond Dwek | C/O United Therapeutics Corporation 1040 Spring Street Silver Spring MD 20910 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-07-08 | 2,160 | $0.00 | 2,160 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-07-11 | 2,160 | $241.29 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit | Disposition | 2022-07-08 | 2,160 | $0.00 | 2,160 | $0.00 |
| Common Stock | Restricted Stock Unit | Acquisiton | 2022-07-07 | 1,750 | $0.00 | 1,750 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-07-08 | No | 4 | M | Direct | |
| 1,750 | 2023-07-07 | No | 4 | A | Direct |
Footnotes
- Shares received upon vesting of restricted stock units on July 8, 2022. Restricted stock units converted on a one-for-one basis into shares of common stock.
- This sale of common stock was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
- Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.
- Annual non-employee director award.
Billionaire Hedge Funds
